Omiya Plant

203-1Miyamae-cho, Nishi-ku, Saitama City, Saitama

■Completion
　July 1977 (Building No. 1)
　April 1981 (Building No. 2)
　March 1990 (Building No. 3)
　February 1996 (Building No. 4)

■Lot area
　9,136m2

Main plant for solid preparations and injectable preparations

At the Omiya Plant, which consists of four facilities, Takata Seiyaku manufactures a variety of drug preparations, ranging from solid oral preparations such as tablets and capsule formulations to freeze-dried and other injection preparations.

Based on our accumulated experience, inside the plant we’ve introduced the state-of-the-art technology and equipment, which we continually seek to upgrade and enhance, for powdered drug products such as granulated powders and dry syrup (DS) and freeze-dried drug products that require special production technologies.

Omiya Plant II

 

639-1, Miyamae-cho, Nishi-ku, Saitama City, Saitama

■Completion
　February 2002

■Lot area
　5,097m2

External preparations manufactured using the state-of-the-art equipment and most advanced technology

Takata’s Omiya Plant II is a specialized facility for steroid preparations for external applications, such as ointments, creams and lotions. We’ve introduced the most advanced production equipment and technology, to create a system consistent from raw materials to final packaging that enables us to achieve highly efficient mass production.

Using the highest level quality control system, we exercise strict control over every process until final shipment. In addition, we’ve achieved a rigorous GMP compliance program, including measures to prevent contamination and protect against various insects, by utilizing a one-way production line and production room barrier system.

Kitasaitama Plant

3207-5, Koguki, KazoCity, Saitama

■Completion
　March 2007

■Lot area
　14,856m2

State-of-the-art dedicated injection manufacturing plant serving diversifying needs

This dedicated injection manufacturing plant produces injection formulations in freeze-dried vial, ampoule solution, and freeze-dried ampoule forms. The facility is state-of-the-art, utilizing unmanned transport systems, CIP/SIP (Cleaning-in-Place/Sterilization-in-Place) processes,automatic sample ejection, and other systems in order to completely eliminate the risk of microbial contamination resulting from production-line workers.

Satte Plant

2100-25, Kamiyoshida, Satte City, Saitama

■Completion
　May 2014

■Lot area
　12,800m2

■Building Area (Floor space)
　Logistic Center Building (with two-stories): 5,200m2
　Solid Preparations for Internal Use Building
　(with five-stories): 17,750m2

■Production Facility
　Furnished with Pharmaceutical Product Manufacturing
　Building and High-potency Manufacturing Building

■Production Capacity
　Tablet: 2 billion tablets every year
　Granule: 600t pellets every year
　High-potency: 200 million units every year

Plant dedicated to solid preparations for internal use, which meets global quality demands

The Satte Plant which produces solid preparations for internal use such as tablets and granules (e.g., fine granules and dry syrup) is a brand new plant complying with the 3-pole GMP and enhancing efficiency through the introduction of state-of-the-art facilities and automatization. At each stage of manufacturing, the production management systems eliminate human errors and the employment of three-dimensional flow bins system enables the plant to completely separate the lines of movement of people and goods and, as a result, to achieve the prevention of the cross-contamination and the contamination by foreign matter. Our company will realize the maximum quality earning trust of our customers.

Tumbling fluidized-bed granulating dryer

Container Blender

Tableting Machine

Powder-bottle filler

PTP filler

Cartoner